Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pacritinib in Combination With Azacitidine in Patients With Chronic Myelomonocytic Leukemia

NCT06159491 is registered in ClinicalTrials.gov with Douglas Tremblay as lead sponsor.

NCT NCT06159491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06159491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pacritinib in Combination With Azacitidine in Patients With Chronic Myelomonocytic Leukemia
Lead sponsor
Douglas Tremblay
Phase
Phase 1/2
Overall status
Recruiting
Start date
September 18, 2024
Completion date
January 31, 2028
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myelomonocytic leukemia